HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 280, Issue , 2015, Pages 29-35

  Sun, Yan ^a,b   Chen, Huoying ^a   Dai, Jiapei ^b   Zou, Huijuan ^a   Gao, Ming ^a   Wu, Hao ^a   Ming, Bingxia ^a   Lai, Lin ^a   Xiao, Yifan ^a   Xiong, Ping ^a   Xu, Yong ^a   Gong, Feili ^a   Zheng, Fang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Astrocyte; Experimental autoimmune encephalomyelitis; High mobility group box 1; Microglia; Neuron

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; ANTIBODY; CD11B ANTIGEN; ENOLASE; FREUND ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; PERTUSSIS TOXIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXTRACELLULAR SPACE; FEMALE; MICROGLIA; MOUSE; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; SPINAL CORD VENTRAL HORN; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MULTIPLE SCLEROSIS; PATHOLOGY; TIME;

ANIMALS; ANTIBODIES; ANTIGENS, CD11B; ASTROCYTES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FREUND'S ADJUVANT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HMGB1 PROTEIN; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PHOSPHOPYRUVATE HYDRATASE; SPINAL CORD; TIME FACTORS;

EID: 84924757042     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.02.005     Document Type: Article

References (37)

1. Agresti A., Lupo R., Bianchi M.E., Muller S. HMGB1 interacts differentially with members of the Rel family of transcription factors. Biochem. Biophys. Res. Commun. 2003, 302:421-426.
2. Andersson U., Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. J. Intern. Med. 2004, 255:344-350.
3. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
4. Andersson A., Covacu R., Sunnemark D., Danilov A.I., Dal Bianco A., Khademi M., Wallstrom E., Lobell A., Brundin L., Lassmann H., Harris R.A. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J. Leukoc. Biol. 2008, 84:1248-1255.
5. Benn T., Halfpenny C., Scolding N. Glial cells as targets for cytotoxic immune mediators. Glia 2001, 36:200-211.
6. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 1997, 75:165-173.
7. Biscetti F., Straface G., De Cristofaro R., Lancellotti S., Rizzo P., Arena V., Stigliano E., Pecorini G., Egashira K., De Angelis G., Ghirlanda G., Flex A. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010, 59:1496-1505.
8. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
9. Fang P., Schachner M., Shen Y.Q. HMGB1 in development and diseases of the central nervous system. Mol. Neurobiol. 2012, 45:499-506.
10. Goodwin G.H., Sanders C., Johns E.W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 1973, 38:14-19.
11. Guazzi S., Strangio A., Franzi A.T., Bianchi M.E. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns 2003, 3:29-33.
12. Hayakawa K., Pham L.D., Katusic Z.S., Arai K., Lo E.H. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:7505-7510.
13. Horner P.J., Gage F.H. Regenerating the damaged central nervous system. Nature 2000, 407:963-970.
14. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275:40096-40105.
15. Kim J.B., Sig Choi J., Yu Y.M., Nam K., Piao C.S., Kim S.W., Lee M.H., Han P.L., Park J.S., Lee J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 2006, 26:6413-6421.
16. Kim J.H., Kim S.J., Lee I.S., Lee M.S., Uematsu S., Akira S., Oh K.I. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway. J. Immunol. 2009, 182:2458-2466.
17. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 1998, 113:147-156.
18. Laird M.D., Shields J.S., Sukumari-Ramesh S., Kimbler D.E., Fessler R.D., Shakir B., Youssef P., Yanasak N., Vender J.R., Dhandapani K.M. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 2014, 62:26-38.
19. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Immunology 2005, 5:331-342.
20. Magna M., Pisetsky D.S. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol. Med. 2014, 20:138-146.
21. Matsuoka N., Itoh T., Watarai H., Sekine-Kondo E., Nagata N., Okamoto K., Mera T., Yamamoto H., Yamada S., Maruyama I., Taniguchi M., Yasunami Y. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J. Clin. Invest. 2010, 120:735-743.
22. Mc Guire C., Prinz M., Beyaert R., van Loo G. Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology. Trends Mol. Med. 2013, 19:604-613.
23. Miller S.D., Karpus W.J., Davidson T.S. Experimental Autoimmune Encephalomyelitis in the Mouse. Current protocols in immunology 2010, (Chapter 15, Unit 15 11). J.E. Coligan (Ed.).
24. Muller S., Ronfani L., Bianchi M.E. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J. Intern. Med. 2004, 255:332-343.
25. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24:641-651.
26. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
27. Pisetsky D.S., Erlandsson-Harris H., Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res. Ther. 2008, 10:209.
28. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:927-938.
29. Robinson A.P., Caldis M.W., Harp C.T., Goings G.E., Miller S.D. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. J. Autoimmun. 2013, 43:32-43.
30. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., Lepantalo M., Carpen O., Parkkinen J., Rauvala H. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004, 104:1174-1182.
31. Schwartz D., Engelhard D., Gallily R., Matoth I., Brenner T. Glial cells production of inflammatory mediators induced by Streptococcus pneumoniae: inhibition by pentoxifylline, low-molecular-weight heparin and dexamethasone. J. Neurol. Sci. 1998, 155:13-22.
32. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
33. Stromnes I.M., Goverman J.M. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 2006, 1:1810-1819.
34. Uzawa A., Mori M., Taniguchi J., Masuda S., Muto M., Kuwabara S. Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2013, 172:37-43.
35. Xia Q., Duan L., Shi L., Zheng F., Gong F., Fang M. High-mobility group box 1 accelerates early acute allograft rejection via enhancing IL-17+ gammadelta T-cell response. Transpl. Int. 2014, 27:399-407.
36. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Wang H., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:296-301.
37. Zou H., Yang Y., Gao M., Zhang B., Ming B., Sun Y., Chen H., Tang X., Chen Z., Xiong P., Xu Y., Fang M., Tan Z., Gong F., Zheng F. HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs. Am. J. Transplant. 2014, 14:1765-1777.